Everolimus - EVERTOR

Evertor (everolimus) is currently used as an immunosuppressant to prevent rejection of organ transplants and in the treatment of renal cell cancer and other tumours. Much research has also been conducted on Evertor (everolimus) and other mTOR inhibitors as targeted therapy for use in a number of cancers.

Approved Uses:

Advanced Breast Cancer

Evertor (Everolimus) Tablets is a prescription medicine used to treat advanced hormone receptor-positive, HER2-negative breast cancer (advanced HR+ BC), along with the medicine exemestane, in postmenopausal women who have already received certain other medicines for their cancer.

Advanced Kidney Cancer Evertor (Everolimus) is a prescription medicine used to treat adults with advanced kidney cancer (renal cell carcinoma or RCC) when certain other medicines have not worked.

Advanced Pancreatic Neuroendocrine Tumor Evertor (Everolimus) is a prescription medicine used to treat adults with a type of pancreatic cancer known as pancreatic neuroendocrine tumor (PNET) that has progressed and cannot be treated with surgery. EVERTOR (EVEROLIMUS) is not for use in people with carcinoid tumors that actively produce hormones.

Progressive GI and Lung Neuroendocrine Tumor Evertor (Everolimus) is a prescription medicine used to treat adults with a type of cancer known as neuroendocrine tumor (NET) of the stomach and intestine (gastrointestinal) or lung that has progressed and cannot be treated with surgery. Evertor (Everolimus) is not for use in people with carcinoid tumors that actively produce hormones.

Renal Angiomyolipoma With Tuberous Sclerosis Complex Evertor (Everolimus) is a prescription medicine used to treat adults with a kidney tumor called angiomyolipoma, seen with a genetic condition called tuberous sclerosis complex (TSC), when their kidney tumor does not require surgery right away.

Evertor (Everolimus) is to be used under medical supervision under guidance from a registered medical practioner